AMPHISTA THERAPEUTICS LIMITED

Company number 11119959

Date	Type	Description	View / Download
23 Mar 2021	AP01	Appointment of Mr Rogier Wouter Rooswinkel as a director on 12 March 2021	(2 pages)
23 Mar 2021	TM01	Termination of appointment of Alessio Ciulli as a director on 12 March 2021	(1 page)
23 Dec 2020	CS01	Confirmation statement made on 19 December 2020 with updates	(7 pages)
16 Dec 2020	AA	Accounts for a small company made up to 31 December 2019	(20 pages)
24 Apr 2020	MA	Memorandum and Articles of Association	(62 pages)
24 Apr 2020	RESOLUTIONS	Resolutions RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of adoption of Articles of Association	(2 pages)
31 Mar 2020	SH01	Statement of capital following an allotment of shares on 30 March 2020 GBP 809.2394	(4 pages)
31 Mar 2020	AP01	Appointment of Dr Satish Jindal as a director on 23 March 2020	(2 pages)
30 Dec 2019	PSC05	Change of details for Advent Life Sciences Llp as a person with significant control on 12 December 2019	(2 pages)
26 Dec 2019	CS01	Confirmation statement made on 19 December 2019 with updates	(6 pages)
20 Dec 2019	RESOLUTIONS	Resolutions RES11 ‐ Resolution of removal of pre-emption rights RES10 ‐ Resolution of allotment of securities	(1 page)
17 Dec 2019	SH01	Statement of capital following an allotment of shares on 12 December 2019 GBP 729.2394	(4 pages)
23 Sep 2019	PSC05	Change of details for Advent Life Sciences Llp as a person with significant control on 28 June 2019	(2 pages)
09 Sep 2019	PSC02	Notification of Advent Life Sciences Llp as a person with significant control on 28 June 2019	(2 pages)
09 Sep 2019	PSC07	Cessation of Advent Life Sciences Fund Ii Lp as a person with significant control on 28 June 2019	(1 page)
09 Sep 2019	PSC02	Notification of Advent Life Sciences Fund Ii Lp as a person with significant control on 28 June 2019	(2 pages)
09 Sep 2019	PSC07	Cessation of Advent Life Sciences Fund Ii Lp as a person with significant control on 20 December 2017	(1 page)
30 Jul 2019	SH01	Statement of capital following an allotment of shares on 28 June 2019 GBP 529.2394	(4 pages)
25 Jul 2019	AP01	Appointment of Dr Nicola Thompson as a director on 8 June 2019	(3 pages)
15 Jul 2019	PSC07	Cessation of Alessio Ciulli as a person with significant control on 28 June 2019	(1 page)
15 Jul 2019	RESOLUTIONS	Resolutions RES13 ‐ Subdivision 28/06/2019 RES10 ‐ Resolution of allotment of securities RES11 ‐ Resolution of removal of pre-emption rights RES01 ‐ Resolution of adoption of Articles of Association	(64 pages)
14 Jul 2019	PSC05	Change of details for Advent Life Sciences Funds Ii Lp as a person with significant control on 20 December 2017	(2 pages)
12 Jul 2019	SH02	Sub-division of shares on 28 June 2019	(4 pages)
04 Feb 2019	RESOLUTIONS	Resolutions RES13 ‐ Re-loan note instrument 23/01/2019 RES11 ‐ Resolution of removal of pre-emption rights	(1 page)
25 Jan 2019	TM01	Termination of appointment of Iyona Rajkomar as a director on 24 January 2019	(1 page)